Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1981-02-02
1983-01-18
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
424266, 546270, A61K 3144, A61K 31455, C07D41704
Patent
active
043691838
ABSTRACT:
The invention concerns novel 2-aryl-1,2-benzisothiazolinone-1,1-dioxide compounds; methods for their preparation; pharmaceutical compositions containing them as an active ingredient; and methods of selectively inhibiting proteases, especially elastase, and of treating emphysema, rheumatoid arthritis, and various inflammatory diseases, for example, bronchial inflammation.
REFERENCES:
patent: 4006007 (1977-02-01), Bollinger
Rasshofer et al., Chem. Abst. 1979, vol. 91, No. 157557p.
Rasshofer et al., Chem. Abst. 1980, vol. 93, No. 132456h.
Fischer et al., Arzneimittel Forschung, 1964, vol. 14 (12), p. 1301.
Stroud, Scientific American, Jul. 1974, pp. 74-88.
Clark Robert L.
Jones Howard
Zimmerman Morris
Arther Thomas E.
Harkaway N.
Jiles Henry R.
Merck & Co. , Inc.
Monaco Mario A.
LandOfFree
2-Pyridyl-1,2-benzisothiazolinone-1,1-dioxides and their use as does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-Pyridyl-1,2-benzisothiazolinone-1,1-dioxides and their use as , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-Pyridyl-1,2-benzisothiazolinone-1,1-dioxides and their use as will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-137176